Product Information
TIMOLOL MALEATE 0.5% EYE DROP is a generic product labeled by Bausch & Lomb Americas Inc., priced at $1.1871 per EA under NDC 82260049605. Its NADAC has been published 156 times since Aug 30, 2023.
FDA first approved this application on Nov 5, 1986. Its Orange Book therapeutic-equivalence code is AT3.
The High Outlier badge above means this manufacturer's average price in the Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6.8 mg/mL
Manufacturer
Bausch & Lomb Americas Inc.NDC
82260049605
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
TIMOLOL MALEATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019463FDA Approved
11/5/1986
TE Code
AT3
On Market Since
2/17/2022
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL MALEATE 0.5% EYE DROP has been published 156 times since Aug 30, 2023, and over the history we have for it it has declined 53.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1871 per EA |
|---|---|
| All-time high | $3.7766 (Jan 10, 2024) |
| All-time low | $1.1871 (Aug 19, 2026) |
| 52-week high | $2.5553 |
| 52-week low | $1.1871 |
| Median price | $2.2728 |
| Average price | $2.2295 |
| Largest weekly change | -49.1% (Jan 17, 2024) |
| Weeks tracked | 156 |
| Tracking since | Aug 30, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIMOLOL MALEATE 0.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL MALEATE 0.5% EYE DROP, manufactured by Bausch & Lomb Americas Inc., is $1.1871 per EA (NDC 82260049605), effective Aug 19, 2026.
How has the price of TIMOLOL MALEATE 0.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for TIMOLOL MALEATE 0.5% EYE DROP has declined 53.6%. It has been tracked across 156 weekly CMS publications since Aug 30, 2023.
What are the highest and lowest recorded NADAC prices for TIMOLOL MALEATE 0.5% EYE DROP?
Since Aug 30, 2023, the NADAC for TIMOLOL MALEATE 0.5% EYE DROP has ranged from a low of $1.1871 (Aug 19, 2026) to a high of $3.7766 (Jan 10, 2024), with a median of $2.2728 per EA.
Are there cheaper alternatives to TIMOLOL MALEATE 0.5% EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TIMOLOL MALEATE 0.5% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures TIMOLOL MALEATE 0.5% EYE DROP?
TIMOLOL MALEATE 0.5% EYE DROP (NDC 82260049605) is labeled by Bausch & Lomb Americas Inc., and CMS classifies it as a generic product.